anacardic acid has been researched along with epidermal growth factor in 1 studies
| Studies (anacardic acid) | Trials (anacardic acid) | Recent Studies (post-2010) (anacardic acid) | Studies (epidermal growth factor) | Trials (epidermal growth factor) | Recent Studies (post-2010) (epidermal growth factor) |
|---|---|---|---|---|---|
| 177 | 1 | 120 | 24,155 | 217 | 4,699 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banerji, A; Bose, C; Kumar, GB; Nair, BG; Nambiar, J; Patel, TB; Venugopal, M | 1 |
1 other study(ies) available for anacardic acid and epidermal growth factor
| Article | Year |
|---|---|
Anacardic acid inhibits gelatinases through the regulation of Spry2, MMP-14, EMMPRIN and RECK.
Topics: Anacardic Acids; Basigin; Cell Adhesion; Cell Line, Tumor; Cell Movement; Epidermal Growth Factor; Gelatinases; Gene Expression Regulation, Enzymologic; GPI-Linked Proteins; Humans; Intracellular Signaling Peptides and Proteins; Matrix Metalloproteinase 14; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Membrane Proteins; Models, Biological; Neoplasm Invasiveness; Signal Transduction; Tissue Inhibitor of Metalloproteinase-2 | 2016 |